English
|
Español
English
|
Español
Insurance
Marketing
Pharmaceuticals
Technology/Innovation
Regulatory
Community
The Medicines Company
Nicholas Gueguen
| Aug 22, 2017
The Medicines Company releases progress report for second quarter
Nicholas Gueguen
| Jul 22, 2017
ORION-1 Phase II data shows promise for inclisiran
Caitlin Nordahl
| Apr 22, 2017
The Medicines Company to highlight its antimicrobial products at conference in Austria
Gene Johnson
| Apr 10, 2017
Medicines Co. webcast highlights clinical trial results of cholesterol-lowering drug
Kyle Perrotti
| Mar 15, 2017
Conference call to review study of inclisiran
Gene Johnson
| Mar 10, 2017
FDA accepts The Medicines Co.'s filing for urinary tract infection drug
Erianne Leatherman
| Mar 3, 2017
FDA accepts priority application for urinary tract infection treatment
Keri Carbaugh
| Jan 10, 2017
Meanwell presents at Morgan Healthcare Conference
Trending
Patient Daily
| Oct 22, 2025
Chronic Care Policy Alliance backs federal legislation to reform the 340B Drug Pricing Program
Patient Daily
| Oct 23, 2025
Dallas Breathe Free ENT Specialist: Humidity 'tends to help' with sinus issues
Patient Daily
| Oct 23, 2025
Capitol Breathe Free Otolaryngologist: ‘Allergy exacerbations are a common trigger for sinus infections'
Patient Daily
| Oct 21, 2025
Gulf Coast Breathe Free Physician Assistant on sinus issues: ‘Certain things like dairy seem to increase mucus production’
